Hapysam 400 Tablet contains S-Adenosyl L-Methionine Disulfate Tosylate 400 mg, a naturally occurring compound involved in numerous biochemical processes within the body. It is primarily utilized as a therapeutic agent to support liver function, improve mood disorders such as depression, and alleviate symptoms associated with osteoarthritis. S-Adenosyl L-Methionine (SAMe) plays a crucial role in methylation reactions, which are essential for the synthesis of neurotransmitters, phospholipids, and nucleic acids. Hapysam 400 is indicated for patients requiring adjunctive treatment for depressive episodes, hepatic disorders including cholestasis and cirrhosis, and joint discomfort due to degenerative arthritis. The medication enhances cellular repair mechanisms and exhibits anti-inflammatory properties, contributing to symptomatic relief and improved quality of life. Hapysam 400 is generally well-tolerated; however, common side effects may include gastrointestinal disturbances such as nausea, abdominal discomfort, and occasional headache. It is contraindicated in individuals with bipolar disorder due to the risk of manic episodes and should be used cautiously in patients taking antidepressants to avoid serotonin syndrome. Dosage and duration of therapy should be individualized based on clinical response and under medical supervision. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse reactions promptly.